|
End-of-day quote
Bulgaria S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 2.920 EUR | +5.42% |
|
+11.45% | +104.98% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.94B 1.77B 1.57B 1.46B 1.33B 2.5B 168B 2.54B 17.52B 6.87B 87.59B 6.64B 6.5B 279B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.49B 2.09B 1.86B 1.72B 1.57B 2.96B 199B 3.01B 20.73B 8.13B 104B 7.86B 7.69B 331B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +5.42% | ||
| 1 week | +11.45% | ||
| Current month | +12.74% | ||
| 1 month | +15.87% | ||
| 3 months | +54.50% | ||
| 6 months | +66.86% | ||
| Current year | +104.98% |
| 1 week | 2.61 |  | 2.95 |
| 1 month | 2.46 | | 2.95 |
| Current year | 1.41 | | 2.95 |
| 1 year | 1.34 | | 2.95 |
| 3 years | 0.94 | | 2.95 |
| 5 years | 0.65 | | 2.95 |
| 10 years | 0.41 | | 2.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.42% | +11.45% | +112.35% | +146.20% | 1.77B | |
| +2.17% | +6.87% | -36.53% | +3.94% | 15.67B | |
| -0.15% | -4.19% | +7.11% | -20.26% | 7.07B | |
| +0.66% | +5.01% | -12.57% | +5.48% | 6.34B | |
| +0.77% | +3.85% | -11.48% | -1.57% | 6.34B | |
| +1.52% | +5.07% | -49.24% | -35.52% | 6.19B | |
| -3.17% | +4.28% | +1.54% | -9.29% | 4.54B | |
| -1.25% | +12.01% | -34.35% | -2.21% | 3.41B | |
| +0.02% | +3.28% | -13.85% | -9.44% | 3.24B | |
| -0.69% | -0.80% | +6.34% | -21.11% | 3.17B | |
| Average | +0.53% | +3.59% | -3.07% | +5.62% | 5.77B | |
| Weighted average by Cap. | +0.70% | +3.59% | -15.86% | -2.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.14B 1.06B 963M 1.82B 122B 1.85B 12.73B 4.99B 63.64B 4.82B 4.72B 203B | 2.63B 1.58B 1.41B 1.3B 1.19B 2.24B 150B 2.27B 15.66B 6.14B 78.31B 5.93B 5.81B 250B |
| Net income | 77.85M 46.75M 41.56M 38.52M 35.05M 66.13M 4.44B 67.2M 463M 182M 2.32B 175M 172M 7.38B | 134M 80.19M 71.28M 66.07M 60.11M 113M 7.61B 115M 794M 311M 3.97B 301M 295M 12.66B |
| Net Debt | 444M 267M 237M 220M 200M 377M 25.32B 383M 2.64B 1.04B 13.21B 1B 980M 42.12B | 541M 325M 289M 268M 244M 460M 30.85B 467M 3.22B 1.26B 16.1B 1.22B 1.19B 51.33B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | €2.920 | +5.42% | 139,942 |
| 15/10/26 | €2.770 | -0.72% | 15,112 |
| 14/10/26 | €2.790 | +5.68% | 89,107 |
| 13/10/26 | €2.640 | +0.76% | 28,254 |
| 12/10/26 | €2.620 | 0.00% | 7,884 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
